120 related articles for article (PubMed ID: 26168705)
1. Cardiovascular disease biomarkers across autoimmune diseases.
Ahearn J; Shields KJ; Liu CC; Manzi S
Clin Immunol; 2015 Nov; 161(1):59-63. PubMed ID: 26168705
[TBL] [Abstract][Full Text] [Related]
2. Is preclinical autoimmunity benign?: The case of cardiovascular disease.
Majka DS; Chang RW
Rheum Dis Clin North Am; 2014 Nov; 40(4):659-68. PubMed ID: 25437283
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerosis in patients with autoimmune disorders.
Frostegård J
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1776-85. PubMed ID: 15976324
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease in autoimmune rheumatic diseases.
Hollan I; Meroni PL; Ahearn JM; Cohen Tervaert JW; Curran S; Goodyear CS; Hestad KA; Kahaleh B; Riggio M; Shields K; Wasko MC
Autoimmun Rev; 2013 Aug; 12(10):1004-15. PubMed ID: 23541482
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for cardiovascular risk assessment in autoimmune diseases.
Teixeira PC; Ferber P; Vuilleumier N; Cutler P
Proteomics Clin Appl; 2015 Feb; 9(1-2):48-57. PubMed ID: 25523513
[TBL] [Abstract][Full Text] [Related]
6. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
Satta N; Frias MA; Vuilleumier N; Pagano S
Curr Pharm Des; 2019; 25(29):3128-3146. PubMed ID: 31470782
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune diseases, their pharmacological treatment and the cardiovascular system.
Jastrzębska M; Czok ME; Guzik P
Cardiol J; 2013; 20(6):569-76. PubMed ID: 24338532
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear antibodies in the general population: positive association with inflammatory and vascular biomarkers but not traditional cardiovascular risk factors.
Solow EB; Vongpatanasin W; Skaug B; Karp DR; Ayers C; de Lemos JA
Clin Exp Rheumatol; 2018; 36(6):1031-1037. PubMed ID: 30299240
[TBL] [Abstract][Full Text] [Related]
9. SLE, atherosclerosis and cardiovascular disease.
Frostegård J
J Intern Med; 2005 Jun; 257(6):485-95. PubMed ID: 15910552
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.
Hahn BH; Grossman J; Chen W; McMahon M
J Autoimmun; 2007; 28(2-3):69-75. PubMed ID: 17433865
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of coronary and carotid imaging rather than traditional atherosclerotic risk factors to identify firefighters at increased risk for cardiovascular disease.
Ratchford EV; Carson KA; Jones SR; Ashen MD
Am J Cardiol; 2014 May; 113(9):1499-504. PubMed ID: 24630792
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
Dessein PH; Joffe BI; Singh S
Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
[TBL] [Abstract][Full Text] [Related]
13. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
14. Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?
Toubi E; Shoenfeld Y
Lupus; 2005; 14(9):665-9. PubMed ID: 16218463
[TBL] [Abstract][Full Text] [Related]
15. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers, erectile dysfunction, and cardiovascular risk prediction: the latest of an evolving concept.
Vlachopoulos C; Ioakeimidis N; Stefanadis C
Asian J Androl; 2015; 17(1):17-20. PubMed ID: 25412676
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and autoimmune diseases in females: The role of microvasculature and dysfunctional endothelium.
Gianturco L; Bodini BD; Atzeni F; Colombo C; Stella D; Sarzi-Puttini P; Drago L; Galaverna S; Turiel M
Atherosclerosis; 2015 Jul; 241(1):259-63. PubMed ID: 25863777
[TBL] [Abstract][Full Text] [Related]
18. T Cells in Autoimmunity-Associated Cardiovascular Diseases.
Schwartz DM; Burma AM; Kitakule MM; Luo Y; Mehta NN
Front Immunol; 2020; 11():588776. PubMed ID: 33117403
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery calcium screening: does it perform better than other cardiovascular risk stratification tools?
Zeb I; Budoff M
Int J Mol Sci; 2015 Mar; 16(3):6606-20. PubMed ID: 25807266
[TBL] [Abstract][Full Text] [Related]
20. Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.
López-Pedrera C; Barbarroja N; Aguirre MA; Torres LA; Velasco F; Cuadrado MJ
Lupus; 2008 Oct; 17(10):904-15. PubMed ID: 18827055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
